His primary areas of study are Surgery, Internal medicine, Cancer, Radiation therapy and Colorectal cancer. His Surgery research is multidisciplinary, incorporating perspectives in Clinical trial and Total mesorectal excision. His Clinical trial study which covers Survival analysis that intersects with Data mining.
As part of his studies on Internal medicine, he frequently links adjacent subjects like Oncology. His Oncology study combines topics in areas such as Young adult, Tamoxifen and Gynecology. The study incorporates disciplines such as Clinical endpoint, Fluorouracil, Capecitabine and Hazard ratio in addition to Radiation therapy.
Hein Putter focuses on Internal medicine, Surgery, Oncology, Breast cancer and Cancer. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology. His research brings together the fields of Clinical trial and Surgery.
His studies deal with areas such as Adjuvant therapy, Gynecology and Cohort as well as Oncology. As part of his studies on Breast cancer, he often connects relevant areas like Chemotherapy. He studies Total mesorectal excision, a branch of Colorectal cancer.
His primary areas of investigation include Internal medicine, Oncology, Breast cancer, Hazard ratio and Cancer. His research on Internal medicine frequently links to adjacent areas such as Gastroenterology. His Cancer study incorporates themes from Lymph node, Randomized controlled trial and Induction chemotherapy.
His studies examine the connections between Endometrial cancer and genetics, as well as such issues in Radiation therapy, with regards to Total mesorectal excision and Clinical endpoint. His Chemotherapy study necessitates a more in-depth grasp of Surgery. His biological study spans a wide range of topics, including Disease and Confidence interval.
The scientist’s investigation covers issues in Internal medicine, Hazard ratio, Surgery, Chemoradiotherapy and Chemotherapy. Hein Putter combines subjects such as Gastroenterology and Oncology with his study of Internal medicine. Hein Putter focuses mostly in the field of Oncology, narrowing it down to topics relating to Proportional hazards model and, in certain cases, Chemotherapy regimen.
His study in Hazard ratio is interdisciplinary in nature, drawing from both Transplantation and Cohort. The various areas that Hein Putter examines in his Surgery study include Disease and Confidence interval. His research in Radiation therapy intersects with topics in Clinical endpoint, Survival analysis and Total mesorectal excision.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter.
The New England Journal of Medicine (2001)
Persistent epigenetic differences associated with prenatal exposure to famine in humans
Bastiaan T. Heijmans;Elmar W. Tobi;Aryeh D. Stein;Hein Putter.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Tutorial in biostatistics: competing risks and multi-state models.
H. Putter;M. Fiocco;R. B. Geskus.
Statistics in Medicine (2007)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun;Hein Putter;Elma Meershoek-Klein Kranenbarg;Mitsuru Sasako.
Lancet Oncology (2010)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg.
Lancet Oncology (2011)
The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma
Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg.
Annals of Surgery (2007)
Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial
H.H. Hartgrink;C.J.H. van de Velde;H. Putter;J.J. Bonenkamp.
Journal of Clinical Oncology (2004)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
RA Nout;Vthbm Smit;H Putter;IM Jürgenliemk-Schulz.
The Lancet (2010)
DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific
Elmar W. Tobi;L.H. Lumey;L.H. Lumey;Rudolf P. Talens;Dennis Kremer.
Human Molecular Genetics (2009)
Competing risks in epidemiology: possibilities and pitfalls
Per Kragh Andersen;Ronald B Geskus;Theo de Witte;Hein Putter.
International Journal of Epidemiology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: